TAM
UTHR icon

Tealwood Asset Management’s United Therapeutics UTHR Stock Holding History

Tealwood Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-23,215
Closed -$2.46M – 92
2016
Q2 		$2.46M Buy
23,215
+540
+2% +$60.2K 1.11% 41
2016
Q1 		$2.53M Buy
22,675
+330
+1% +$41.8K 1.13% 42
2015
Q4 		$2.75M Buy
22,345
+553
+3% +$80.5K 1.29% 36
2015
Q3 		$2.86M Sell
21,792
-184
-0.8% -$29.5K 1.25% 37
2015
Q2 		$3.82M Buy
21,976
+905
+4% +$163K 1.49% 26
2015
Q1 		$3.63M Sell
21,071
-26,515
-56% -$4.04M 1.49% 28
2014
Q4 		$6.16M Sell
47,586
-4,863
-9% -$627K 2.43% 4
2014
Q3 		$6.75M Buy
52,449
+16,810
+47% +$1.73M 2.64% 3
2014
Q2 		$3.15M Sell
35,639
-641
-2% -$61.6K 1.28% 34
2014
Q1 		$3.41M Buy
36,280
+300
+0.8% +$30.7K 1.38% 28
2013
Q4 		$4.07M Sell
35,980
-375
-1% -$33.8K 1.64% 21
2013
Q3 		$2.87M Sell
36,355
-33,550
-48% -$2.45M 1.27% 32
2013
Q2 		$4.6M Buy
+69,905
New +$4.5M 2.3% 8

Other funds holding UTHR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Tealwood Asset Management's UTHR Position: Q3 2016 in Review

Tealwood Asset Management sold out of United Therapeutics (UTHR) in Q3 2016, closing a stake of 23,215 shares — an estimated $2.46M sold.

Tealwood Asset Management first reported a position in UTHR in Q2 2013 and held it in 13 quarters. The position peaked at $6.75M in Q3 2014. 394 funds tracked by Wall St. Rank hold UTHR as of Q3 2016.

  • Tealwood Asset Management reported no remaining United Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Tealwood Asset Management sold 23,215 United Therapeutics shares in Q3 2016, an estimated $2.46M.
  • Tealwood Asset Management first reported a position in United Therapeutics in Q2 2013 and held it in 13 quarters.
  • Tealwood Asset Management's United Therapeutics position peaked at $6.75M in Q3 2014.
  • 394 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2016.

Based on Tealwood Asset Management's 13F filing for Q3 2016, filed 9 Nov 2016.